Report cover image

Global Interventional Oncology Market Growth, Size, Trends Analysis- By Technique, By Procedure, By Applications, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Oct 14, 2025
Length 244 Pages
SKU # SPER20565946

Description

Interventional Oncology Market Introduction and Overview

According to SPER market research, ‘Global Interventional Oncology Market Size- By Technique, By Procedure, By Applications, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ states that Global Interventional Oncology Market is projected to be worth 6.29 billion by 2034 and is anticipated to surge at a CAGR of 8.83%.

A speciality area of medicine called interventional oncology focuses on using minimally invasive, image-guided techniques to diagnose and treat cancer. It encompasses techniques such as tumor ablation, embolization, and targeted drug delivery, which allow physicians to treat cancerous tissues accurately while minimizing harm to surrounding healthy areas. These approaches offer significant advantages over conventional treatments like surgery and radiation, including shorter recovery times, fewer complications, and enhanced patient comfort.

Restraints:

The Global Interventional Oncology Market is facing several challenges due to the high cost of procedures, which limits widespread adoption. Treatments such as TACE, TARE, and percutaneous ablation require advanced and specialized equipment, including Yttrium-90, sophisticated catheters, embolic agents, and state-of-the-art imaging systems, making production and scaling expensive. Additionally, these procedures demand highly skilled interventional radiologists and trained support staff, further increasing overall costs.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered By

Technique, By Procedure, By Applications, By End-use

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

AngioDynamics Inc., Boston Scientific Corporation, Cook Medical, GE Healthcare, Johnson & Johnson (Ethicon), Medtronic plc, Profound Medical, Siemens Healthineers, Stryker Corporation, and Teleflex Incorporated.

Global Interventional Oncology Market Segmentation:

By Technique: Based on the Technique, Global Interventional Oncology Market is segmented as; Ablation Therapies, Embolization Therapies.

By Procedure: Based on the Procedure, Global Interventional Oncology Market is segmented as; Tumor Ablation, Tumor Biopsy, Vascular Intervention, Palliative Care.

By Applications: Based on the Applications, Global Interventional Oncology Market is segmented as; Liver Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Breast Cancer.

By End-Use: Based on the End-Use, Global Interventional Oncology Market is segmented as; Hospitals, Specialty Clinics.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

244 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Interventional Oncology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Interventional Oncology Market
7. Global Interventional Oncology Market, By Technique (USD Million) 2021-2034
7.1. Ablation Therapies
7.1.1. Radiofrequency Ablation (RFA)
7.1.2. Microwave Ablation (MWA)
7.1.3. Cryoablation
7.1.4. Laser Ablation
7.1.5. Irreversible Electroporation (IRE)
7.2. Embolization Therapies
7.2.1. Transarterial Chemoembolization (TACE)
7.2.2. Transarterial Radioembolization (TARE)
7.3. Biopsy Techniques
7.3.1. Core Needle Biopsy
7.3.2. Fine Needle Aspiration (FNA)
7.4. Targeted Therapy Delivery Systems
7.4.1. Drug-Eluting Beads
7.4.2. Radioembolization
7.4.3. Drug-Eluting Stents
7.4.4. Injectable Hydrogels and Nanoparticles
7.4.5. Other Targeted Therapy Systems
7.5. Image-Guided Procedures
7.5.1. Ultrasound Guidance
7.5.2. CT Scan Guidance
7.5.3. MRI Guidance
7.5.4. Fluoroscopy Guidance
8. Global Interventional Oncology Market, By Procedure (USD Million) 2021-2034
8.1. Tumor Ablation
8.2. Tumor Biopsy
8.3. Vascular Interventions
8.4. Palliative Care
9. Global Interventional Oncology Market, By Applications (USD Million) 2021-2034
9.1. Liver Cancer
9.2. Lung Cancer
9.3. Kidney Cancer
9.4. Prostate Cancer
9.5. Breast Cancer
9.6. Other Cancer
10. Global Interventional Oncology Market, By End-Use (USD Million) 2021-2034
10.1. Hospitals
10.2. Specialty Clinics
11. Global Interventional Oncology Market, (USD Million) 2021-2034
11.1. Global Interventional Oncology Market Size and Market Share
12. Global Interventional Oncology Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. AngioDynamics Inc.
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Boston Scientific Corporation
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Cook Medical
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. GE Healthcare
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Johnson & Johnson (Ethicon)
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Medtronic plc
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Profound Medical
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Siemens Healthineers
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Stryker Corporation
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.10. Teleflex Incorporated
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us